Kenneth Pryde

Company: AstraZeneca

Job title: Associate Director, Oncology Safety Sciences

Seminars:

Employing Small Intestinal Organoids to Assess Clinical Risk for Oncotherapies 3:15 pm

Outlining our experimental approach/capabilities/strategy for intestinal organoid application to support safer drug discovery – include cross-modality and cross-species data examples Introducing novel predictive models we are developing in AZ to better quantify human diarrhoea risk Understanding the advancements of these models after a yearRead more

day: Day 1 Track B PM